Millstone Medical Outsourcing, LLC has announced that the company will expand its Memphis, Tennessee, operations to a new facility in order to broaden services and capacity. The new facility will offer 150, 000 square feet of operational space for advanced mechanical inspection, world-class loaner kit processing, innovative bone/tissue storage, cutting-edge packaging services, and distribution. With construction of a new building and state-of-the-art renovations already underway, the expansion to the additional location is expected to be complete by the end of the fourth quarter of 2012.
Millstone Expands Leaps and Bounds
1 min read Premium comments
Secondary
The new facility will be located in Olive Branch, Mississippi, which is a suburb of Memphis. Memphis professionals and staff will make the move with Millstone Medical, and the company plans to hire employees for an additional 25 positions.
“Millstone Medical is preparing for explosive growth, ” said Chris Ramsden, chief executive officer of Millstone Medical Outsourcing, in the August 28, 2012 news release. “The additional operational space will allow Millstone to expand programs for existing customers and to bring on new customers. In addition, the new facility is strategically located near the distribution hubs of the area’s major carrier and continues to enable Millstone to provide extended service hours and expedited shipping. We are tremendously excited about all the possibilities the new facility will deliver for the company and our customers.”
Regarding the 25 new employees, Ramsden tells OTW,
The new employees will be doing loaner kit processing and advanced mechanical inspection…areas of growth for Millstone; we will also be hiring inspectors to meet customer demand in both those areas. Millstone is a FDA registered and state licensed human bone and tissue bank. This aspect of our business is growing as more orthopedic OEMs rollout these types of innovative products.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.